NDC codes

FDA NDC Directory
Product NDC (as listed)60505-0833Labeler and product segments. Claims need a package NDC.
Product NDC at billing width60505-0833Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
60505-0833-5605050833051 BOTTLE, SPRAY in 1 CARTON (60505-0833-5) / 200 SPRAY, METERED in 1 BOTTLE, SPRAYMarketed from Mar 1, 2010

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Azelastine Hydrochloride
Generic name (nonproprietary)
azelastine hydrochloride
Active ingredients
Azelastine hydrochloride — 137 ug/1
Dosage form
Spray, Metered
Route
Nasal
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 077954
Marketing start
Listing expires
Other FDA classes
Histamine H1 Receptor Antagonists (Mechanism)
Identifiers
Product ID 60505-0833_1609cf10-ae35-1f3e-0d03-3d7caa05a1adSPL ID 1609cf10-ae35-1f3e-0d03-3d7caa05a1adSPL set ID 4f58c203-f649-a18e-aaf3-70b0797652f4RxCUI 1797867UNII 0L591QR10I
Pharmacologic class
Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505083305 followed by a unit qualifier and the quantity

Package 60505-0833-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Azelastine hydrochloride nasal spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. Azelastine hydrochloride nasal spray is an H1-receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077954

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077954
ProductStrengthForm · routeLabelerProduct NDC
Azelastine HydrochlorideAzelastine hydrochloride 137 ug/1Spray, MeteredNasalPreferred Pharmaceuticals Inc.68788-4056
Azelastine HydrochlorideAzelastine hydrochloride 137 ug/1Spray, MeteredNasalProficient Rx LP71205-449
Azelastine HydrochlorideAzelastine hydrochloride 137 ug/1Spray, MeteredNasalA-S Medication Solutions50090-2330

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in